Titlebook: Colorectal Cancer Liver Metastases; A Comprehensive Guid Mauro Monteiro Correia,Michael A. Choti,Go Wakabay Book 2020 Springer Nature Switz

顯赫的人

使成波狀

https://doi.org/10.1007/978-3-030-32778-1ectable and the patient has an asymptomatic primary colon cancer, upfront surgical resection rather than initial chemotherapy may be offered for medically fit patients. In this chapter we discuss and summarise treatment algorithms for different presentations.

凹槽

圣人

Molecular Biomarkers for the Management of Colorectal Cancer Liver Metastases,omarkers. In the near future, these biomarkers may be routinely used for guiding patient selection for surgical resection of CRLM, the choice and timing of systemic therapy, the sequencing of treatments, and individualizing patient-specific risk of recurrence and disease-related mortality.

熒光

Prognostic Factors of Colorectal Cancer Liver Metastasis,l to metastatic disease, and R0 resection), and related to extrahepatic metastatic disease..The evolution of studies on prognostic factors related to colorectal liver metastases is bringing more personalized information, individualizing these patients and their treatment.

兩種語(yǔ)言

能得到

搜尋

PRO

甜食